Descriptor: "SUCCINATES" / Publication Type: Reports - Searchworks@Jio Institute Digital Library Search Results

Searchworks

Select search scope, currently: Articles

Catalog

books, media & more in Jio Institute collections

Articles

journal articles & other e-resources

Your search keyword '"SUCCINATES"' showing total 5 results

Start Over Descriptor "SUCCINATES" Publication Type Reports

5 results on '"SUCCINATES"'

1. Strides Pharma Science's arm gets USFDA's nod for Solifenacin Succinate Tablets.

Subjects: SUCCINATES, DRUG tablets, DRUG approval
Abstract: The US market for Solifenacin Succinate Tablets, 5 mg and 10 mg is approximately $820 million [ABSTRACT FROM AUTHOR]
Published: 2019

2. Glenmark Pharmaceuticals' arm receives ANDA approval for Solifenacin Succinate Tablets.

Subjects: SUCCINATES, BUSINESS partnerships, SALES reporting
Abstract: The company continues to identify and explore external development partnerships to supplement and accelerate the growth of its existing pipeline and portfolio [ABSTRACT FROM AUTHOR]
Published: 2019

3. Glenmark surges with arm receiving ANDA approval for Solifenacin Succinate Tablets.

Subjects: BUSINESS partnerships, SUCCINATES, MARKET capitalization
Abstract: The company continues to identify and explore external development partnerships to supplement and accelerate the growth of its existing pipeline and portfolio [ABSTRACT FROM AUTHOR]
Published: 2019

4. Alembic Pharmaceuticals gets USFDA approval for Solifenacin Succinate Tablets.

Subjects: SUCCINATES, DRUG approval, OVERACTIVE bladder, BLADDER abnormalities
Abstract: Solifenacin Succinate Tablet is a muscarinic antagonist indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and urinary frequency [ABSTRACT FROM AUTHOR]
Published: 2019

5. Alembic Pharmaceuticals gains on getting USFDA approval for Solifenacin Succinate Tablets.

Subjects: MUSCARINIC antagonists, SUCCINATES, DRUG approval, MARKET capitalization
Abstract: Solifenacin Succinate Tablet is a muscarinic antagonist indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and urinary frequency [ABSTRACT FROM AUTHOR]
Published: 2019

Catalog

Books, media, physical & digital resources

See catalog results